Thursday, March 28, 2024
spot_img
HomeNewsCaribbean NewsWHO drops hydroxychloroquine from solidarity trial 

WHO drops hydroxychloroquine from solidarity trial 

GENEVA, Switzerland — World Health Organization (WHO) has announced that the hydroxychloroquine (HCQ) arm of the Solidarity Trial to find an effective COVID-19 treatment was being stopped.

The trial’s executive group and principal investigators made the decision based on evidence from the Solidarity Trial, UK’s Recovery trial, and a Cochrane review of other evidence on hydroxychloroquine.

Data from Solidarity (including the French Discovery trial data) and the recently announced results from the UKs Recovery trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care.

Investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial. Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician.

This decision applies only to the conduct of the Solidarity trial and does not apply to the use or evaluation of hydroxychloroquine in pre- or post-exposure prophylaxis in patients exposed to COVID-19.

spot_img
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img
spot_img
spot_img

Caribbean News

Haiti: ‘Cataclysmic’ situation demands immediate and bold action, UN report

GENEVA, Switzerland – A UN Human Rights Office report published today calls for immediate and bold action to tackle the “cataclysmic” situation in Haiti. “Corruption, impunity and...

Global News

World Bank Group publishes new data, aiming to boost investment in emerging markets

Data shows untapped potential, resilience in emerging markets. WASHINGTON, USA - The World Bank Group on March 28, 2024, published sought-after proprietary statistics that...